Real world evidence on 5661 patients treated for macular oedema secondary to branch retinal vein occlusion with intravitreal anti-vascular endothelial growth factor, intravitreal dexamethasone or macular laser

BACKGROUND/AIMS: Clinical trials suggest anti-vascular endothelial growth factor is more effective than intravitreal dexamethasone as treatment for macular oedema secondary to branch retinal vein occlusion. This study asks if ‘real world’ data from a larger and more diverse population, followed for...

Descripción completa

Detalles Bibliográficos
Autores principales: Gale, Richard, Pikoula, Maria, Lee, Aaron Y, Denaxas, Spiros, Egan, Catherine, Tufail, Adnan, Taylor, Paul
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2021
Materias:
Clinical Science
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8005793/
https://www.ncbi.nlm.nih.gov/pubmed/32532760
http://dx.doi.org/10.1136/bjophthalmol-2020-315836

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8005793/
https://www.ncbi.nlm.nih.gov/pubmed/32532760
http://dx.doi.org/10.1136/bjophthalmol-2020-315836

Ejemplares similares